MLchartDataset catalogue

Singulair

Term · Oncology and biomedicine · MLC-T-ONC-007782

A drug used to treat symptoms of asthma, such as trouble breathing, tight chest, wheezing, coughing, and runny nose. Singulair blocks the action of a substance that causes airways in the lungs to narrow and causes other symptoms of asthma. It is a type of leukotriene receptor antagonist and a type of antiasthmatic agent. Also called montelukast sodium.

Table 1. Record
IdentifierMLC-T-ONC-007782
FieldOncology and biomedicine
Synonymsmontelukast sodium
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-007782",
  "term": "Singulair",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat symptoms of asthma, such as trouble breathing, tight chest, wheezing, coughing, and runny nose. Singulair blocks the action of a substance that causes airways in the lungs to narrow and causes other symptoms of asthma. It is a type of leukotriene receptor antagonist and a type of antiasthmatic agent. Also called montelukast sodium.",
  "synonyms": [
    "montelukast sodium"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/singulair/"
}

Record 15,018 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.